Since mid nineties, research at the Hemato-Oncology section of the dept. of Clinical Chemistry and Hematology in UMC Utrecht is focused on development and subsequent clinical translation of novel immunotherapy strategies for hematological malignancies, in particular for multiple myeloma (MM). These research activities are highly integrated with the clinical profile of the dept of Hematology. In this short overview, we will provide the specific goals and the current status of this research.
|Number of pages||4|
|Journal||Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde|
|Publication status||Published - 1 Jan 2012|